Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Finished Goods (2022 - 2025)

Envoy Medical's Finished Goods history spans 4 years, with the latest figure at $165000.0 for Q3 2025.

  • For Q3 2025, Finished Goods rose 26.92% year-over-year to $165000.0; the TTM value through Sep 2025 reached $165000.0, up 26.92%, while the annual FY2024 figure was $119000.0, 41.67% up from the prior year.
  • Finished Goods for Q3 2025 was $165000.0 at Envoy Medical, up from $120000.0 in the prior quarter.
  • Across five years, Finished Goods topped out at $165000.0 in Q3 2025 and bottomed at $84000.0 in Q4 2023.
  • The 4-year median for Finished Goods is $120500.0 (2022), against an average of $123200.0.
  • The largest annual shift saw Finished Goods plummeted 30.58% in 2023 before it skyrocketed 54.72% in 2025.
  • A 4-year view of Finished Goods shows it stood at $121000.0 in 2022, then tumbled by 30.58% to $84000.0 in 2023, then skyrocketed by 41.67% to $119000.0 in 2024, then soared by 38.66% to $165000.0 in 2025.
  • Per Business Quant, the three most recent readings for COCH's Finished Goods are $165000.0 (Q3 2025), $120000.0 (Q2 2025), and $164000.0 (Q1 2025).